UK markets closed

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.47+0.23 (+4.39%)
At close: 04:00PM EDT
5.44 -0.03 (-0.55%)
After hours: 06:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-27,489
-22,288
-29,020
-20,023
-13,657
Depreciation & amortisation
420.174
1,069
533.131
245.697
143.89
Stock-based compensation
4,091
7,392
4,459
2,966
1,953
Change in working capital
28,864
-11,752
28,748
263.667
1,506
Accounts payable
1,326
1,326
1,208
991.166
1,827
Other working capital
3,685
-27,644
1,557
-18,006
-10,602
Other non-cash items
-24.282
-24.282
161.74
48.395
-
Net cash provided by operating activities
6,191
-25,597
4,917
-16,809
-10,055
Cash flows from investing activities
Investments in property, plant and equipment
-2,506
-2,048
-3,360
-1,196
-547.601
Purchases of investments
-82,175
-97,442
-114,219
0
-6,130
Sales/maturities of investments
44,098
104,597
82,506
0
12,117
Net cash used for investing activities
-40,583
5,108
-35,073
-1,196
5,439
Cash flows from financing activities
Common stock issued
1,879
25,515
4,804
20,174
27,343
Common stock repurchased
-
-
-
-
0
Net cash used provided by (used for) financing activities
1,967
25,580
4,874
20,225
33,382
Net change in cash
-32,426
5,092
-25,282
2,219
28,767
Cash at beginning of period
40,839
9,603
34,885
32,666
3,899
Cash at end of period
8,414
14,695
9,603
34,885
32,666
Free cash flow
Operating cash flow
6,191
-25,597
4,917
-16,809
-10,055
Capital expenditure
-2,506
-2,048
-3,360
-1,196
-547.601
Free cash flow
3,685
-27,644
1,557
-18,006
-10,602